Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Nature of Operations and Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Restricted Cash

Restricted Cash	9 Months Ended
Sep. 30, 2019
Restricted Cash [Abstract]
Restricted Cash	NOTE 5 – RESTRICTED CASH Restricted cash, which is reported within other assets and restricted cash on the condensed consolidated balance sheets, consists of cash and cash equivalents held as collateral for a corporate credit card and office space in New York. As such, the cash and cash equivalents are restricted in use.

Restricted Cash

9 Months Ended

Sep. 30, 2019

Restricted Cash [Abstract]

Restricted Cash

NOTE 5 – RESTRICTED CASH

Restricted cash, which is reported within other assets and restricted cash on the condensed consolidated balance sheets, consists of cash and cash equivalents held as collateral for a corporate credit card and office space in New York. As such, the cash and cash equivalents are restricted in use.